This company has been marked as potentially delisted and may not be actively trading. NASDAQ:CLXT Calyxt (CLXT) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Calyxt Stock (NASDAQ:CLXT) 30 days 90 days 365 days Advanced Chart Get Calyxt alerts:Sign Up Key Stats Today's Range$6.01▼$7.7750-Day Range$6.30▼$31.5052-Week Range$1.25▼$7.77Volume254,056 shsAverage Volume139,308 shsMarket Capitalization$31.31 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewCalyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company to enhance the quality of alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota.Read More… Receive CLXT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Calyxt and its competitors with MarketBeat's FREE daily newsletter. Email Address CLXT Stock News HeadlinesCalyxt stockholders approve merger and reverse stock split; anticipated name change and ticker symbol for combined companyMay 20, 2023 | seekingalpha.comCalyxt Announces Stockholder Approval of Merger With CibusMay 19, 2023 | finance.yahoo.comClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code... And since then, "in the know" patriots have quietly used this same "Trump loophole" to shield their life savings from the economic chaos. But with Trump now forcefully bringing back millions of manufacturing jobs from Mexico, China, and the entire BRICS anti-dollar coalition...April 26, 2025 | American Alternative (Ad)Calyxt Reports First Quarter 2023 Financial Results and Provides Corporate UpdateMay 1, 2023 | finance.yahoo.comCalyxt Completes One-for-Ten Reverse Stock SplitApril 24, 2023 | finance.yahoo.comCalyxt, Inc. Announces Effectiveness of Registration Statement on Form S-4 in Connection with Merger with Cibus Global LLCApril 18, 2023 | finance.yahoo.comCalyxt, Inc.: Calyxt Announces Effective Date of Reverse Stock SplitApril 13, 2023 | finanznachrichten.deCalyxt Announces Effective Date of Reverse Stock SplitApril 7, 2023 | finance.yahoo.comSee More Headlines CLXT Stock Analysis - Frequently Asked Questions How were Calyxt's earnings last quarter? Calyxt, Inc. (NASDAQ:CLXT) issued its quarterly earnings data on Monday, May, 1st. The company reported ($5.45) EPS for the quarter, missing the consensus estimate of ($3.00) by $2.45. The company earned $0.04 million during the quarter. Calyxt had a negative trailing twelve-month return on equity of 259.69% and a negative net margin of 9,979.64%. When did Calyxt's stock split? Calyxt shares reverse split on the morning of Thursday, June 1st 2023. The 1-5 reverse split was announced on Thursday, June 1st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 1st 2023. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split. When did Calyxt IPO? Calyxt (CLXT) raised $101 million in an initial public offering (IPO) on Thursday, July 20th 2017. The company issued 6,100,000 shares at a price of $15.00-$18.00 per share. Citigroup, Credit Suisse, JefferiesWells and Fargo Securities served as the underwriters for the IPO and BMO Capital Markets and Ladenburg Thalmann were co-managers. What other stocks do shareholders of Calyxt own? Based on aggregate information from My MarketBeat watchlists, some other companies that Calyxt investors own include Cellectis (CLLS), Intel (INTC), Plug Power (PLUG), First Solar (FSLR), Intellia Therapeutics (NTLA), NVIDIA (NVDA) and Sorrento Therapeutics (SRNE). Company Calendar Last Earnings5/01/2023Today4/26/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolNASDAQ:CLXT CIK1705843 Webwww.calyxt.com Phone(651) 683-2807FaxN/AEmployees48Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($3.49) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-16,890,000.00 Net Margins-9,979.64% Pretax Margin-9,979.64% Return on Equity-259.69% Return on Assets-83.22% Debt Debt-to-Equity RatioN/A Current Ratio0.61 Quick Ratio0.61 Sales & Book Value Annual Sales$160,000.00 Price / Sales195.69 Cash FlowN/A Price / Cash FlowN/A Book Value$0.54 per share Price / Book11.67Miscellaneous Outstanding Shares4,970,000Free Float4,865,000Market Cap$31.31 million OptionableNot Optionable Beta1.98 Social Links Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NASDAQ:CLXT) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calyxt, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Calyxt With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.